176 related articles for article (PubMed ID: 24490170)
1. Suppression of osteopontin functions by levocetirizine, a histamine H1 receptor antagonist, in vitro.
Komatsuzaki T; Suzaki I; Hirano K; Kanai K; Asano K; Suzaki H
Biomed Res Int; 2013; 2013():735835. PubMed ID: 24490170
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo.
Kanei A; Asano K; Kanai K; Furuta A; Sasaki K; Suzaki H
In Vivo; 2014; 28(4):657-66. PubMed ID: 24982238
[TBL] [Abstract][Full Text] [Related]
3. Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro.
Asano K; Kanai K; Suzaki H
Arzneimittelforschung; 2004; 54(8):436-43. PubMed ID: 15460210
[TBL] [Abstract][Full Text] [Related]
4. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
Asano K; Kanai KI; Suzaki H
Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
[TBL] [Abstract][Full Text] [Related]
5. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
6. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
8. Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells.
Shih MY; Hsu JY; Weng YS; Fu LS
Allergy Asthma Proc; 2008; 29(5):480-5. PubMed ID: 18926057
[TBL] [Abstract][Full Text] [Related]
9. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
10. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of H1 antihistamines: clinical relevance.
Simons FE
Am J Med; 2002 Dec; 113 Suppl 9A():38S-46S. PubMed ID: 12517581
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa.
Fujikura T; Shimosawa T; Yakuo I
J Allergy Clin Immunol; 2001 Jan; 107(1):123-8. PubMed ID: 11150001
[TBL] [Abstract][Full Text] [Related]
13. The expression of osteopontin and its association with Clara cell 10 kDa protein in allergic rhinitis.
Liu Y; Lu X; Yu HJ; Hua XY; Cui YH; Huang SK; Liu Z
Clin Exp Allergy; 2010 Nov; 40(11):1632-41. PubMed ID: 20553297
[TBL] [Abstract][Full Text] [Related]
14. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.
Horak F; Zieglmayer PU; Zieglmayer R; Kavina A; Lemell P
Br J Clin Pharmacol; 2005 Jul; 60(1):24-31. PubMed ID: 15963090
[TBL] [Abstract][Full Text] [Related]
15. Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo.
Asano K; Kanai K; Furuta A; Furuya A; Suzaki H; Hisamitsu T
J Pharm Pharmacol; 2007 Oct; 59(10):1389-95. PubMed ID: 17910814
[TBL] [Abstract][Full Text] [Related]
16. Histamine H
Fukui H; Mizuguchi H; Nemoto H; Kitamura Y; Kashiwada Y; Takeda N
Handb Exp Pharmacol; 2017; 241():161-169. PubMed ID: 27885525
[TBL] [Abstract][Full Text] [Related]
17. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
18. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children.
Simons FE; J Semus M; Goritz SS; Simons KJ
Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
20. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
